9/10/2023 0 Comments Molecular diagnostics stock![]() This represented a significant increase of 135.29% from the last price of $2.55. According to data from CNN Money, the one analyst offering a 12-month price forecast for HTGM had a median target of $6.00, with a high estimate of $6.00 and a low estimate of $6.00. (HTGM) was closely watched by investors and analysts alike. On May 24, 2023, the stock performance of HTG Molecular Diagnostics Inc. The company does not have any executives to display. In the previous year, the company reported an annual revenue of $6.4 million and an annual profit of -$21.6 million, resulting in a net profit margin of -339.20%. The company’s next reporting date is scheduled for August 8, 2023, with an earnings per share (EPS) forecast of -$1.84 for this quarter. HTGM’s corporate headquarters is located in Tucson, Arizona. These ratios suggest that the stock may be undervalued. The price-to-earnings (P/E) ratio for HTGM is not available (NM), while the price-to-sales ratio is 0.56, and the price-to-book ratio is 1.17. However, the revenue growth for the same period was -28.52%. ![]() HTGM’s market capitalization was $6.3 million, and the company reported an earnings growth of 18.14% last year. Throughout the day, the stock traded within a range of $2.55 to $2.70, with a volume of 2,800 shares traded. (HTGM) opened at $2.70, slightly lower than the previous day’s closing price of $2.75. On May 24, 2023, HTG Molecular Diagnostics Inc. (HTGM) Stock Analysis: Undervalued with Promising Earnings Growth The company is determined to take the necessary steps to regain compliance and maintain its position on the Nasdaq stock exchange. has taken action by appealing the delisting determination by Nasdaq. This notice indicates that the company is not in compliance with a listing rule or standard and could potentially be delisted from the Nasdaq stock exchange if it fails to regain compliance. was served with a notice of delisting or failure to meet a continued listing rule or standard from The Nasdaq Stock Market LLC. On May 18, 2023, HTG Molecular Diagnostics, Inc. The opinions expressed in this article are those of the writer, subject to the Publishing Guidelines. On the date of publication, David Moadel did not have (either directly or indirectly) any positions in the securities mentioned in this article. Be ready for sizable share price moves, and possibly more reverse splits if shares fall in 2023 like they did in 2022. If you choose to invest in HTG Molecular Diagnostics now, just understand that small-cap stocks can be quite volatile. This doesn’t necessarily mean shares will continue to stay above those levels, however. HTGM stock is now far above $1 and firmly above $5, so those issues are resolved for the time being. This is crucial because the Nasdaq exchange has been known to sometimes delist stocks when they stay below $1 for too long, and because sub-$5 stocks are sometimes called penny stocks. HTG Molecular Diagnostics shares trade on the Nasdaq exchange, and now they’re above $5. Thus, it appears that HTG Molecular Diagnostics investors are generally pleased with the reverse share split.Īlso, here’s an important point to keep in mind. On a split-adjusted basis, HTGM stock rallied 4% to 5% early in today’s trading session before fading somewhat. So, the investors aren’t suddenly fabulously wealthy - but they are enjoying some price appreciation today. In other words, HTG Molecular Diagnostics investors will now have one share worth 12 times as much instead of 12 cheaper shares. HTG Molecular Diagnostics announced a 1-for-12 reverse stock split yesterday, and shares started trading on a split-adjusted basis this morning. HTGM stock is higher in price than it was yesterday, but there’s a specific reason for that. Yet, a stock representing a small business can still make a big move. Its market capitalization of around $88 million gives an indication of just how tiny HTG Molecular Diagnostics is. Before you jump into the trade, however, it’s probably a good idea to learn the specifics of the stock split and how the shareholders are responding to it.īased in Arizona, HTG Molecular Diagnostics is a very small life sciences company. Due to a reverse share split, HTGM stock is suddenly more expensive. Some investors of HTG Molecular Diagnostics (NASDAQ: HTGM) got a big surprise today.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |